GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase rlmn (Q5FUA9)

Analyse AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q5FUA9
Type
protein
Length
407 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x7c7eF5512E51Bcd3d8e1379AFF339AD78CFbD034
Molecule
Dual-specificity RNA methyltransferase rlmn
UniProt
Q5FUA9
Pockets
4 · best druggability 0.76

Structure

1 distinct chain · 36% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual-specificity RNA methyltransferase rlmnprotein40736% helix, 17% strandQ5FUA9

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15850.760.8266empty
21010.520.8323empty
3870.390.7721empty
4510.250.7313empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.